NYSE American · MLSSHealthcareOrthopedic & Surgical Supplies

Milestone Scientific, Inc. Common Stock (MLSS)

$0.3170+4.31%
Close Nov 4, 2026 · split-adjusted
Nov 2, 2026$0.32▼ 23.03% in range
Nov 3, 2025Low $0.25 · High $0.55Nov 2, 2026
What changed · written from our data
As of Nov 4, 2026

Milestone Scientific closed at $0.32 on Nov 4, up 4.31%, 42.7% below its 52-week closing high. Volume of 16.3K shares was 0.18× its 20-day average (below normal).

Split-adjusted performance: -13.6% over one month, -21.4% over six months, -24.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $2.84M, up 22.3% from a year earlier, with a net margin of -37.3%.

Short interest was 81.2K shares at the Oct 15 settlement, down 5.9% from the prior report (0.1% of float, 1.0 days to cover).

Market cap$28.7M90.6M shares
Revenue · quarter$2.8M+22.3% YoY
Diluted EPS$-0.01—
P/E · TTM—P/S 3.0×
Net margin-37.3%Gross 67.2%
Dividend yieldNone
52-week range0.25 – 0.55−42.7% from high
Volume16.3K0.18× 20-day avg
Volatility · 60d64.8%Annualised
Short % of float0.1%1.0 days to cover
Net cash$1.6MCash $2.1M
Next earnings—Not scheduled
Split-adjusted performance
1W +0.1%1M −13.6%3M −31.8%6M −21.4%YTD +16.1%1Y −24.3%3Y −64.8%5Y −84.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum10
Revenue growth79
Net margin26
Value (low P/E)—
Size10

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →
Shares short81.2K−5.9% vs prior
Days to cover1.0Settled Oct 15
% of float0.1%
Short vol. 10d17.7%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
MLSSMilestone Scientific$0.3170+4.31%−21.4%+22.3%−37.3%—$28.7M
LFWDLifeward$6.03+3.34%−13.9%+15.7%−173.9%—$17.1MCompare
MYOMyomo$1.29+0.78%+51.2%+21.3%−34.4%—$51.1MCompare
COCHEnvoy Medical$6.88+3.85%+1.8%−34.6%−14258.8%—$53.2MCompare
APTAlpha Pro Tech$5.71+2.70%+21.5%+12.0%9.8%13.9$58.3MCompare
SPAISafe Pro Group$3.25+2.52%−27.3%+1336.2%−237.9%—$66.2MCompare
CNXUConexeu Sciences$2.17−8.82%————$66.9MCompare
NTRBNutriband$6.09−3.10%+53.5%−29.7%−201.3%—$74.1MCompare
LAKELakeland Industries$8.96+0.22%−7.0%−4.5%−9.8%—$89.0MCompare

Quick answers

What does Milestone Scientific do?
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time.
What is MLSS's market cap?
$28.72M, based on the Nov 4 close of $0.32.
Does Milestone Scientific pay a dividend?
No regular cash dividend has been paid in the last year.
How much of MLSS is sold short?
81.2K shares, 0.1% of float, as of Oct 15, 2026.
What sector is MLSS in?
Healthcare, in the Orthopedic & Surgical Supplies industry.

About Milestone Scientific

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

HQ: Livingston, NJ15 employeesListed Nov 3, 1995milestonescientific.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology